Regencell extends insider lock-up to April 2027

Regencell Bioscience Holdings Limited has extended the lock-up period for directors and employees who previously received stock options. All such employees agreed that 100% of their shares and vested options will remain locked up for an additional 12 months, until April 20, 2027. Directors agreed that between 82% and 92% of their shares and vested options will also remain subject to this extended lock-up over the same period. A standard form of this fifth lock-up extension is included as an exhibit and is governed by New York law.

https://www.stocktitan.net/sec-filings/RGC/6-k-regencell-bioscience-holdings-ltd-current-report-foreign-issuer-96ca02bf901e.html